Nephrology & Therapeutics

Renal cell cancer

Renal cell cancer is a disease in which malignant (cancer) cells form in proximal convoluted tubules of the kidney. Renal cell carcinoma is the most common type of kidney cancer in adults. It occurs most often in men 50 to 70 years old .Blacks are at higher risk than whites Renal cell carcinoma (RCC) is also called Hypernephroma, Renal adenocarcinoma or Grawitz’s tumor. Smoking and misuse of certain pain medicines can affect the risk of renal cell cancer. Hereditary factors have a minor impact on individual susceptibility to the disease. Signs of renal cell cancer include blood in the urine and a lump in the abdomen. Tests that examine the abdomen and kidneys are used to detect and diagnose renal cell cancer some of which include CT scan,IVP, blood chemistry studies, urinalysis etc. The principal treatment options may include surgery, molecular-targeted therapy, immunotherapy. The recommended treatment for renal cell cancer may be Nephrectomy or partial nephrectomy, surgical removal of all or part of the kidney. The incidence of RCC varies between sexes, ages, races and geographic location around the world. Men have a higher incidence than women. The incidence of the cancer has been increasing in frequency worldwide at a rate of approximately 2–3% per decade until the last few years where the number of new cases has stabilised.